Cancellation and Postponement of Medical Information System Implementations Due to the Spread of COVID-19
First written in FY2020-Q2. 4 of 10 entries say "Restated". Latest entry: FY2023.
Software Service moved to the "Worse" side of this theme in 2020, 1 year before the typical company in this theme (2021).
The whole theme swung hardest in 2024: 5 of 21 companies on the "Worse" side.
6 other companies' latest entry also says "Softened".
- FY2023SoftenedAnnual report
「If infectious diseases such as COVID-19 and influenza were to emerge and spread, becoming prolonged and more serious, customer medical institutions would presumably place greater emphasis on policies such as prioritising measures to address those diseases.」
The risk was reframed from one limited to COVID-19 to the general risk of cancelled or postponed implementations due to infectious diseases. Meanwhile, the wording on countermeasures changed to indicate that they would be implemented "as necessary." - FY2022RestatedAnnual report
「During the consolidated fiscal year, the Company advanced thorough infection-control measures and remote implementation work, among other initiatives, resulting in a limited impact of COVID-19 on performance.」
The Company continued to explain that the impact of COVID-19 on performance was limited as a result of infection-control measures and remote implementation work. - FY2022-Q2RestatedAnnual report
「During the second quarter of the consolidated cumulative period, the impact of COVID-19 on business performance was limited, partly because we thoroughly implemented infection-control measures and advanced remote implementation work.」
The Company continued to explain that the impact of COVID-19 on performance was limited as a result of infection-control measures and remote implementation work. - FY2022-Q1RestatedAnnual report
「During the first quarter of the consolidated cumulative period, the impact of COVID-19 on business performance was limited, partly because we thoroughly implemented infection-control measures and advanced remote implementation work.」
The Company continued to explain that the impact of COVID-19 on performance was limited as a result of infection-control measures and remote implementation work. - FY2021MitigatedAnnual report
「During the consolidated fiscal year, while the Company was affected by the spread of COVID-19, medical institutions' investment appetite did not decline significantly. The Group also took thorough infection-control measures and advanced remote implementation work, among other initiatives, resulting in a limited impact on performance.」
The Company stated that the impact on performance during the fiscal year was limited as a result of thorough infection-control measures and remote implementation work. - FY2021-Q3RestatedAnnual report
「Some projects have also experienced delays in commencing operations due to the impact of COVID-19. However, investment sentiment among medical institutions has not deteriorated, and the impact remains limited at this time.」
The Company stated that postponements of medical information system project launches due to the impact of COVID-19 continued to occur. Meanwhile, it explained that the impact remained limited at that time. - FY2021-Q2MaterialisedAnnual report
「Some projects have also experienced delays in commencing operations due to the impact of COVID-19. However, investment sentiment among medical institutions has not deteriorated, and the impact remains limited at this time.」
The Company stated that postponements of medical information system project launches had actually occurred due to the impact of COVID-19. Meanwhile, it explained that medical institutions' investment appetite had not declined and that the impact was limited. - FY2020MaterialisedAnnual report
「Meanwhile, the management of medical institutions has also become more difficult as a result of COVID-19, and a tendency to postpone capital expenditures for the time being was observed.」
In relation to the risk of cancelled or postponed implementations identified in the previous filing, the Company stated that deterioration in medical institutions' operating conditions and postponement of capital expenditures had actually been observed. - FY2020-Q3WorsenedAnnual report
「Meanwhile, the management of medical institutions has also become more difficult as a result of COVID-19, and there has been a tendency to postpone capital expenditures for the time being.」
The deterioration in medical institutions' operating conditions and the tendency to postpone capital expenditures were newly disclosed. The impact associated with the risk of cancelled or postponed medical information system implementations was specified. - FY2020-Q2First statedAnnual report
「If the impact of COVID-19 were to become prolonged and more serious, customer medical institutions would presumably place greater emphasis on policies such as prioritising measures to address the disease. If this resulted in a large number of medical institutions cancelling or postponing the implementation of medical information systems, it could affect the Company's performance.」
The Company newly identified as a business and other risk the possibility that prolonged and more serious COVID-19 would lead medical institutions to prioritise infection-control measures, resulting in numerous cancellations or postponements of medical information system implementations.